HuGE Literature Finder
Records 1-4
|
ASXL1 mutations, previous vascular complications and age at diagnosis predict survival in 85 WHO-defined polycythaemia vera patients.
British journal of haematology 2020 Feb . Andréasson Björn, Pettersson Helna, Wasslavik Carina, Johansson Peter, Palmqvist Lars, Asp Jul |
|
TET2 mutations in Ph-negative myeloproliferative neoplasms: identification of three novel mutations and relationship with clinical and laboratory findings.
BioMed research international 2013 2013 929840. Patriarca Andrea, Colaizzo Donatella, Tiscia Gianluca, Spadano Raffaele, Di Zacomo Silvia, Spadano Antonio, Villanova Ida, Margaglione Maurizio, Grandone Elvira, Dragani Alfre |
|
Prevalence and clinical outcomes of the 46/1 haplotype, Janus kinase 2 mutations, and ten-eleven translocation 2 mutations in Budd-Chiari syndrome and their impact on thrombotic complications post liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2012 Jul 18 (7): 819-27. Westbrook Rachel H, Lea Nicholas C, Mohamedali Azim M, Smith Alexander E, Orr David W, Roberts Lara N, Heaton Nigel D, Wendon Julia A, O'Grady John G, Heneghan Michael A, Mufti Ghulam |
|
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis.
Leukemia 2009 May 23 (5): 905-11. Tefferi A, Pardanani A, Lim K-H, Abdel-Wahab O, Lasho T L, Patel J, Gangat N, Finke C M, Schwager S, Mullally A, Li C-Y, Hanson C A, Mesa R, Bernard O, Delhommeau F, Vainchenker W, Gilliland D G, Levine R |
- Page last reviewed:Mar 16, 2019
- Page last updated:Aug 05, 2020
- Content source: